When a member is unwell abroad and needs to come home, “repatriation” can mean very different things. At one end sits a fully equipped air ambulance with a critical-care team. At the other, a nurse or doctor escorting a stable patient home on a scheduled commercial flight. In between are stretcher arrangements, ground transfers and everything that has to be coordinated around them.
The cost gap between those options is enormous. So is the clinical difference. Getting the choice right is where good repatriation is made or lost.
The most expensive option is rarely the safest
There is a reflex, when a case looks serious, to reach for the air ambulance. Sometimes that is exactly right and nothing else will do. Often it is not. A stable patient flown by dedicated jet when a nurse-escorted commercial flight would have been clinically appropriate is a large, avoidable cost, and it can mean a slower, more disruptive journey for the patient too.
Equally, under-triaging is dangerous. Putting a patient who needs continuous monitoring onto a commercial flight to save money is a clinical failure, not a cost saving. The decision cannot be driven by the invoice. It has to be driven by the clinical picture.
The four options, and what separates them
The choice is not binary, and treating it as jet-or-not is where most of the avoidable cost enters.
Dedicated air ambulance. For patients who are ventilated, haemodynamically unstable, or who need monitoring and the ability to intervene at altitude. Expensive, and the only defensible answer when the clinical picture demands it.
Commercial stretcher. For the patient who cannot sit but is stable, on a scheduled service with a clinical escort and the equipment the journey requires. Clinically capable of far more than people assume, and a fraction of the cost.
Seated medical escort. For the patient who can travel in a seat but needs supervision, medication management, oxygen or assistance through the airport.
Assisted travel. For the recovered patient who needs documentation and practical help rather than clinical care.
What separates them is not how serious the diagnosis sounds. It is what the patient’s physiology will tolerate over the specific sector in question, and what care they will credibly need in the air. A stable patient with a fixed femoral fracture is a stretcher case. A patient with a chest drain and borderline oxygenation facing a twelve-hour sector is not.
Sector length changes the answer
The same patient is a different transport decision from Malaga and from Bangkok, and this is routinely underweighted.
A two-hour European sector is forgiving: oxygen planning is simple, immobility is brief, one escort is not fatigued, and a diversion airfield with real capability is rarely far away. An eleven-hour sector changes all four. Total oxygen requirement multiplies, thromboembolic risk rises in a patient who may already be immobile, infusions need managing across a full duty period, and there is no useful diversion over open water.
A patient entirely fit to fly home from Spain may need several more days of stabilisation before the same journey from Thailand is safe. Assessing that against the patient’s actual trajectory, the direction they are moving in rather than the snapshot on the day somebody asked, is the judgement that matters most.
The decision is clinical, and it should be owned
Every repatriation should turn on the same questions. What is the patient’s condition, and how might it change in the air? What level of care do they need in transit? Where are they going, and is there a bed and a consultant ready to receive them? Those are questions for a clinician who is accountable for the answer, not for whoever is nearest the phone.
Where repatriations actually go wrong
Very little of the risk is in the air. It is in the transitions, and in the things nobody owns:
- The ground leg at origin. Subcontracted locally, unbriefed, and the point at which a patient most often deteriorates unobserved.
- The clinical record. Promised by email, still not sent, and the receiving team meets the patient before the notes.
- Fitness assessed once. A judgement made on Tuesday for a Friday flight, never revisited when the picture changed on Wednesday.
- The receiving bed. Assumed rather than secured, so the transfer ends in an emergency department while someone starts ringing round.
- The handover. A signature on a delivery note rather than a clinical exchange between two teams.
Each is unglamorous. Each is where continuity of care is actually lost.
Bed to bed, not just a flight home
Getting someone onto a plane is not the end of the job. Good repatriation is coordinated bed to bed, into an appropriate UK NHS or private bed matched to the care pathway, drawing on our vetted transport and receiving network, so the patient arrives at the right level of care rather than simply arriving. That continuity is the difference between a transfer and a genuine handover of care.
When not to repatriate
The unfashionable half of the argument. Sometimes the right answer is to leave the patient where they are.
If the local facility is genuinely capable, the definitive treatment can be completed to a good standard, and the patient is not yet fit to travel, then moving them early is a clinical risk taken for a commercial reason. It is also frequently a false economy: transferring a sick patient costs more than transferring a recovered one, and a deterioration in transit costs more than either.
The test is whether the ongoing pathway needs to be at home, meaning rehabilitation, staged reconstruction or continuity with a UK consultant. Not whether the daily rate is uncomfortable. Those are different questions and they have different answers.
Done well, the clinically appropriate repatriation is usually also the defensible one and the affordable one. That is not a coincidence. It is what happens when clinicians, not costs, make the call.
For how much of this varies by country, and it varies a great deal, see medical repatriation by country.
